Acessibilidade / Reportar erro

Presentation of the Therapy Program for Management of Chronic Cough

ABSTRACT

Purpose

To present a proposal for speech-language pathology rehabilitation called the Therapy Program for Management of Chronic Cough (TMCC) for the treatment of refractory chronic cough.

Methods

TMCC was developed based on two stages: literature and clinical analysis. The literature analysis stage was carried out through the following procedures: electronic and manual search for articles and books published until June 2019 that included adult participants with chronic cough and intervention with speech-language pathology therapy; selection of sources; analysis of articles and books included; and, preparation of the initial version of the therapy program. The initial version of the therapy program resulting from literature analysis stage was submitted to clinical analysis stage through the following procedures: analysis by three judges; revision of the proposal by the authors; judges’ re-analysis; elaboration of the final version called the Therapy Program for Management of Chronic Cough (TMCC).

Results

TMCC synthesizes scientific knowledge and current clinical experience on the behavioral management of refractory chronic cough into a program with three main components, each one with specific objectives and strategies. TMCC consists of four sessions, with weekly frequency and duration between 30-45 minutes per session, executed in hierarchical phases, with specific objectives and strategies per session.

Conclusion

TMCC is a program structured to offer global cough rehabilitation. To obtain scientific evidence about its effectiveness is necessary, so that it can be used in clinical practice.

Keywords:
Larynx; Rehabilitation; Behavioral Therapy; Therapeutics; Cough

RESUMO

Objetivo

Apresentar uma proposta de reabilitação fonoaudiológica denominada Programa de Terapia para Manejo da Tosse Crônica (TMTC) para tratamento da tosse crônica refratária.

Método

O TMTC foi elaborado com base em duas etapas: análise de literatura e análise clínica. A etapa de análise de literatura foi realizada por meio dos procedimentos: busca eletrônica e manual por artigos e livros publicados até junho de 2019 que contemplassem participantes adultos com tosse crônica, e intervenção com terapia fonoaudiológica; seleção das fontes; análise dos artigos e livros incluídos; e, elaboração da versão inicial do programa de terapia. A versão inicial do programa de terapia resultante da etapa de análise de literatura foi submetida a etapa de análise clínica por meio dos procedimentos: análise de três juízes; revisão da proposta pelos autores; reanálise dos juízes; elaboração da versão final denominada Programa de Terapia para Manejo da Tosse Crônica (TMTC).

Resultados

O TMTC sintetiza o conhecimento científico e a experiência clínica atual sobre o manejo comportamental da tosse crônica refratária em um programa com três componentes principais, cada um com objetivos e estratégias específicos. O TMTC é composto por quatro sessões, com frequência semanal, e duração entre 30 e 45 minutos por sessão, executadas em fases hierárquicas, com objetivos e estratégias específicos por sessão.

Conclusão

O TMTC é um programa estruturado para oferecer uma reabilitação global da tosse. Faz-se necessário obter evidências científicas sobre sua efetividade para que ele possa ser utilizado na prática clínica.

Descritores:
Laringe; Reabilitação; Terapia Comportamental; Terapêutica; Tosse

INTRODUCTION

The larynx has several functions, including phonation, breathing and protection of the lower airways. The laryngeal function of protecting the lower airways is vital for survival and occurs from a protective reflex, called cough. Cough is a reflex resulting from the activation of irritating receptors in the airway(11 Vertigan AE, Theodoros DG, Gibson PG, Winkworth AL. The relationship between chronic cough and paradoxical vocal fold movement: a review of the literature. J Voice. 2006;20(3):466-80. http://dx.doi.org/10.1016/j.jvoice.2005.08.001. PMid:16274959.
http://dx.doi.org/10.1016/j.jvoice.2005....
). This is a maneuver of forced expiration against an initially closed glottis, with subsequent opening of the glottis and the production of an expulsive sound(22 Morice AH, McGarvey L, Pavord I. Recommendations for the management of cough in adults. Thorax. 2006;61(Supl 1):1-24. http://dx.doi.org/10.1136/thx.2006.065144. PMid:16936230.
http://dx.doi.org/10.1136/thx.2006.06514...
).

Cough can be classified into acute, subacute and chronic, according to persistence duration. Cough is considered chronic when it persists for more than eight weeks(33 Poulose V, Bin Mohd I. Prolonged cough presenting with diagnostic difficulty: a study of aetiological and clinical outcomes. Singapore Med J. 2011;52(4):267-70. PMid:21552788.). Cases of cough that persist after medical treatment are called refractory(44 Gibson PG, Vertigan AE. Speech pathology for chronic cough: a new approach. Pulm Pharmacol Ther. 2009;22(2):159-62. http://dx.doi.org/10.1016/j.pupt.2008.11.005. PMid:19061964.
http://dx.doi.org/10.1016/j.pupt.2008.11...

5 Vertigan AE, Kapela SL, Ryan NM, Birring SS, McElduff P, Gibson PG. Pregabalin and speech pathology combination therapy for refractory chronic cough a randomized controlled trial. Chest. 2016;149(3):639-48. http://dx.doi.org/10.1378/chest.15-1271. PMid:26447687.
http://dx.doi.org/10.1378/chest.15-1271...
-66 Vertigan A, Gibson P. Speech pathology management of cronic refractory cough and related disorders. Oxford, UK: Coptom Publishing; 2016.). Chronic cough affects up to 20% of the adult population(22 Morice AH, McGarvey L, Pavord I. Recommendations for the management of cough in adults. Thorax. 2006;61(Supl 1):1-24. http://dx.doi.org/10.1136/thx.2006.065144. PMid:16936230.
http://dx.doi.org/10.1136/thx.2006.06514...
) and is refractory to medical treatment in up to 46% of cases(55 Vertigan AE, Kapela SL, Ryan NM, Birring SS, McElduff P, Gibson PG. Pregabalin and speech pathology combination therapy for refractory chronic cough a randomized controlled trial. Chest. 2016;149(3):639-48. http://dx.doi.org/10.1378/chest.15-1271. PMid:26447687.
http://dx.doi.org/10.1378/chest.15-1271...
,77 Vertigan AE, Kapela SM, Franke I, Gibson PG. The effect of a vocal loading test on cough and phonation in patients with chronic cough. J Voice. 2017;31(6):763-72. http://dx.doi.org/10.1016/j.jvoice.2017.03.020. PMid:28461166.
http://dx.doi.org/10.1016/j.jvoice.2017....
,88 Ryan NM, Gibson PG. Recent additions in the treatment of cough. J Thorac Dis. 2014;6(Supl 7):S739-47. http://dx.doi.org/10.3978/j.issn.2072-1439.2014.03.13. PMid:25383209.
http://dx.doi.org/10.3978/j.issn.2072-14...
). Refractory chronic cough is more common in women(22 Morice AH, McGarvey L, Pavord I. Recommendations for the management of cough in adults. Thorax. 2006;61(Supl 1):1-24. http://dx.doi.org/10.1136/thx.2006.065144. PMid:16936230.
http://dx.doi.org/10.1136/thx.2006.06514...
,99 Chamberlain S, Birring SS, Garrod R. Nonpharmacological interventions for refractory chronic cough patients: systematic review. Lung. 2014;192(1):75-85. http://dx.doi.org/10.1007/s00408-013-9508-y. PMid:24121952.
http://dx.doi.org/10.1007/s00408-013-950...
), beginning in middle age(22 Morice AH, McGarvey L, Pavord I. Recommendations for the management of cough in adults. Thorax. 2006;61(Supl 1):1-24. http://dx.doi.org/10.1136/thx.2006.065144. PMid:16936230.
http://dx.doi.org/10.1136/thx.2006.06514...
,99 Chamberlain S, Birring SS, Garrod R. Nonpharmacological interventions for refractory chronic cough patients: systematic review. Lung. 2014;192(1):75-85. http://dx.doi.org/10.1007/s00408-013-9508-y. PMid:24121952.
http://dx.doi.org/10.1007/s00408-013-950...
).

Currently, chronic cough is considered a primary condition characterized by afferent neuronal hypersensitivity(88 Ryan NM, Gibson PG. Recent additions in the treatment of cough. J Thorac Dis. 2014;6(Supl 7):S739-47. http://dx.doi.org/10.3978/j.issn.2072-1439.2014.03.13. PMid:25383209.
http://dx.doi.org/10.3978/j.issn.2072-14...
). Central neural mechanisms are believed to be involved since patients with refractory chronic cough have abnormal laryngeal sensations such as discomfort, pain, or tingling; increased sensitivity to stimuli that do not trigger coughing or that are subliminal for that sensation; and, cough triggered in response to non-coughing stimuli or urgency-to-cough(88 Ryan NM, Gibson PG. Recent additions in the treatment of cough. J Thorac Dis. 2014;6(Supl 7):S739-47. http://dx.doi.org/10.3978/j.issn.2072-1439.2014.03.13. PMid:25383209.
http://dx.doi.org/10.3978/j.issn.2072-14...
).

Treatment approaches for refractory chronic cough include cough suppression therapy and use of anti-cough drugs(55 Vertigan AE, Kapela SL, Ryan NM, Birring SS, McElduff P, Gibson PG. Pregabalin and speech pathology combination therapy for refractory chronic cough a randomized controlled trial. Chest. 2016;149(3):639-48. http://dx.doi.org/10.1378/chest.15-1271. PMid:26447687.
http://dx.doi.org/10.1378/chest.15-1271...
,99 Chamberlain S, Birring SS, Garrod R. Nonpharmacological interventions for refractory chronic cough patients: systematic review. Lung. 2014;192(1):75-85. http://dx.doi.org/10.1007/s00408-013-9508-y. PMid:24121952.
http://dx.doi.org/10.1007/s00408-013-950...
,1010 Gibson P, Wang G, McGarvey L, Vertigan AE, Altman KW, Birring SS, et al. Treatment of unexplained chronic cough chest guideline and expert panel report. Chest. 2016;149(1):27-44. http://dx.doi.org/10.1378/chest.15-1496. PMid:26426314.
http://dx.doi.org/10.1378/chest.15-1496...
). Speech-Language Pathology therapy is a potentially efficient intervention in managing refractory chronic cough and seeks to break the cycle of reciprocal irritation of cough receptors when medical intervention fails(11 Vertigan AE, Theodoros DG, Gibson PG, Winkworth AL. The relationship between chronic cough and paradoxical vocal fold movement: a review of the literature. J Voice. 2006;20(3):466-80. http://dx.doi.org/10.1016/j.jvoice.2005.08.001. PMid:16274959.
http://dx.doi.org/10.1016/j.jvoice.2005....
). The mechanism underlying the improvement is not fully understood, but it may include active cough suppression, reduced cough reflex sensitivity, or increased cough reflex threshold(1111 Ryan NM, Vertigan AE, Bone S, Gibson PG. Cough reflex sensitivity improves with speech language pathology management of refractory chronic cough. Cough. 2010;6(1):5. http://dx.doi.org/10.1186/1745-9974-6-5. PMid:20663225.
http://dx.doi.org/10.1186/1745-9974-6-5...
,1212 Chamberlain S, Garrod R, Birring SS. Cough suppression therapy: does it work? Pulm Pharmacol Ther. 2013;26(5):524-7. http://dx.doi.org/10.1016/j.pupt.2013.03.012. PMid:23524013.
http://dx.doi.org/10.1016/j.pupt.2013.03...
), in addition to reduced laryngeal irritation(1111 Ryan NM, Vertigan AE, Bone S, Gibson PG. Cough reflex sensitivity improves with speech language pathology management of refractory chronic cough. Cough. 2010;6(1):5. http://dx.doi.org/10.1186/1745-9974-6-5. PMid:20663225.
http://dx.doi.org/10.1186/1745-9974-6-5...
).

Little scientific evidence is available to support the effectiveness of Speech-Language Pathology management of refractory chronic cough. However, some studies(1313 Vertigan AE, Theodoros DG, Gibson PG, Winkworth AL. Efficacy of speech pathology management for chronic cough: A randomised placebo controlled trial of treatment efficacy. Thorax. 2006;61(12):1065-9. http://dx.doi.org/10.1136/thx.2006.064337. PMid:16844725.
http://dx.doi.org/10.1136/thx.2006.06433...
,1414 Vertigan AE, Theodoros DG, Winkworth AL, Gibson PG. A Comparison of two approaches to the treatment of chronic cough: perceptual, acoustic, and electroglottographic outcomes. J Voice. 2008;22(5):581-9. http://dx.doi.org/10.1016/j.jvoice.2007.01.001. PMid:17485195.
http://dx.doi.org/10.1016/j.jvoice.2007....
) point to reduced sensitivity to cough reflex; respiratory, cough, and voice symptoms; improvement in maximum phonation time, acoustic parameters and cough-related quality of life. Furthermore, no method is described in the literature with sufficient details to allow its replication, and evidence of effectiveness proven through studies with high methodological rigor. A specific rehabilitation method that meets the real needs of individuals with refractory chronic cough needs to be developed.

Thus, the objective of the present study was to present a proposal for Speech-Language Pathology rehabilitation called the Therapy Program for Management of Chronic Cough (TMCC) for the treatment of refractory chronic cough.

METHODS

TMCC was developed based on two steps: a literature analysis and a clinical analysis.

The literature analysis stage was carried out based on the following procedures:

  1. a

    Electronic and manual search for articles and books published until June 2019 that included the following characteristics: Participants: adult individuals with chronic cough; Intervention: Speech-Language Pathology therapy;

  2. b

    Electronic search in the Clinical Trials, Cochrane Library, Embase, LILACS, PUBMED and Science Web databases, from a search strategy elaborated with the keywords “cough” and “therapy”;

  3. c

    Manual search performed by scanning references of the selected articles, from the inclusion of at least one of the keywords in the title: “cough” and “therapy”;

  4. d

    From the selection, ten articles(22 Morice AH, McGarvey L, Pavord I. Recommendations for the management of cough in adults. Thorax. 2006;61(Supl 1):1-24. http://dx.doi.org/10.1136/thx.2006.065144. PMid:16936230.
    http://dx.doi.org/10.1136/thx.2006.06514...
    ,44 Gibson PG, Vertigan AE. Speech pathology for chronic cough: a new approach. Pulm Pharmacol Ther. 2009;22(2):159-62. http://dx.doi.org/10.1016/j.pupt.2008.11.005. PMid:19061964.
    http://dx.doi.org/10.1016/j.pupt.2008.11...
    ,55 Vertigan AE, Kapela SL, Ryan NM, Birring SS, McElduff P, Gibson PG. Pregabalin and speech pathology combination therapy for refractory chronic cough a randomized controlled trial. Chest. 2016;149(3):639-48. http://dx.doi.org/10.1378/chest.15-1271. PMid:26447687.
    http://dx.doi.org/10.1378/chest.15-1271...
    ,77 Vertigan AE, Kapela SM, Franke I, Gibson PG. The effect of a vocal loading test on cough and phonation in patients with chronic cough. J Voice. 2017;31(6):763-72. http://dx.doi.org/10.1016/j.jvoice.2017.03.020. PMid:28461166.
    http://dx.doi.org/10.1016/j.jvoice.2017....

    8 Ryan NM, Gibson PG. Recent additions in the treatment of cough. J Thorac Dis. 2014;6(Supl 7):S739-47. http://dx.doi.org/10.3978/j.issn.2072-1439.2014.03.13. PMid:25383209.
    http://dx.doi.org/10.3978/j.issn.2072-14...
    -99 Chamberlain S, Birring SS, Garrod R. Nonpharmacological interventions for refractory chronic cough patients: systematic review. Lung. 2014;192(1):75-85. http://dx.doi.org/10.1007/s00408-013-9508-y. PMid:24121952.
    http://dx.doi.org/10.1007/s00408-013-950...
    ,1111 Ryan NM, Vertigan AE, Bone S, Gibson PG. Cough reflex sensitivity improves with speech language pathology management of refractory chronic cough. Cough. 2010;6(1):5. http://dx.doi.org/10.1186/1745-9974-6-5. PMid:20663225.
    http://dx.doi.org/10.1186/1745-9974-6-5...

    12 Chamberlain S, Garrod R, Birring SS. Cough suppression therapy: does it work? Pulm Pharmacol Ther. 2013;26(5):524-7. http://dx.doi.org/10.1016/j.pupt.2013.03.012. PMid:23524013.
    http://dx.doi.org/10.1016/j.pupt.2013.03...

    13 Vertigan AE, Theodoros DG, Gibson PG, Winkworth AL. Efficacy of speech pathology management for chronic cough: A randomised placebo controlled trial of treatment efficacy. Thorax. 2006;61(12):1065-9. http://dx.doi.org/10.1136/thx.2006.064337. PMid:16844725.
    http://dx.doi.org/10.1136/thx.2006.06433...
    -1414 Vertigan AE, Theodoros DG, Winkworth AL, Gibson PG. A Comparison of two approaches to the treatment of chronic cough: perceptual, acoustic, and electroglottographic outcomes. J Voice. 2008;22(5):581-9. http://dx.doi.org/10.1016/j.jvoice.2007.01.001. PMid:17485195.
    http://dx.doi.org/10.1016/j.jvoice.2007....
    ) and two books(66 Vertigan A, Gibson P. Speech pathology management of cronic refractory cough and related disorders. Oxford, UK: Coptom Publishing; 2016.,1515 Carroll TL. Chronic cough. San Diego, CA: LOGO Plural Publishing; 2019.) were included;

  5. e

    Analysis of the articles and books included;

  6. f

    Elaboration of the initial version of the therapy program considering the most frequent techniques in the consulted literature and their specific objectives.

The initial version of the therapy program resulting from the literature analysis stage was submitted to the clinical analysis stage using the following procedures:

  1. a

    Analysis of three judges, Speech-Language Pathologist, voice and/or dysphagia specialists, with experience in treating chronic cough, independently. The judges were instructed to consider the characteristics and clinical needs of the patients, and the applicability of the therapy. For changes or exclusion of techniques, the agreement between at least two judges was considered;

  2. b

    Proposal review by the authors;

  3. c

    Re-analysis of the judges, together;

  4. d

    Elaboration of the final version called the Therapy Program for Management of Chronic Cough (TMCC).

RESULTS

The TMCC proposed as a Speech-Language Pathology intervention has three main components with specific objectives and strategies. The three components of the program are 1) Counseling on cough and laryngeal well-being; 2) Cough suppression, control and replacement; 3) Respiratory and laryngeal control in the functions of breathing, coughing and phonation.

The cough counseling component and laryngeal well-being seek to provide simple and useful information on chronic cough, laryngeal well-being and control of laryngeal irritants. The strategies used for this purpose are to provide counseling with the support of educational material on the larynx, cough, triggers and the development of voluntary cough control; as well as on laryngeal well-being and the control of irritating factors.

The cough suppression, control and substitution component seek to enable the patient to learn to anticipate when a cough will occur and thus prevent and/or interrupt coughing episodes through the use of cough suppression, control and substitution techniques. For this purpose, the strategies used are: a) Mapping the cough, b) Performing a hierarchical training with distraction techniques from the focus of attention, suppression techniques and cough control techniques, performed in four phases: 1) Train in a clinical situation without the cough trigger (learn); 2) Train outside the clinical environment when asymptomatic (automate); 3) Train outside the clinical environment when symptomatic to replace or suppress cough in risky situations; 4) Continuous use of techniques with exposure to triggers.

The respiratory and laryngeal control component seeks to train respiratory coordination, work on pneumophonoarticulatory coordination (PPAC), reduce the tension of the accessory laryngeal muscles, adjust the resonance focus, mobilize the vocal fold mucosa, decrease phonatory effort and constriction supraglottic and stabilize glottic closure. The strategies used for this axis are respiratory and vocal training through guidance and exercises.

The details of the strategies can be seen in Chart 1. The strategies are distributed in the sessions to allow the execution of the program hierarchically. The hierarchy follows three stages: sensory awareness - seeks to identify and recalibrate the sensory system; voluntary behavioral substitution – seeks to use sensory awareness to execute strategies voluntarily; and, generalization – seeks to modify the body demand and automate the practice so that the strategies are implemented involuntarily.

Chart 1
Description of the components and strategies of the Therapy Program for Management of Chronic Cough

The TMCC consists of four sessions, with weekly frequency, and duration between 30 and 45 minutes per session. Adaptations in the number of sessions can be performed according to the time of learning and development of the patient, and two additional sessions can be inserted to fix phonatory and respiratory adjustments, and automate the distraction techniques of the focus of attention, suppression and cough control. Besides, the patient must perform the exercises at home, five times a day, except for exercises that have specific recommendations.

The description of the TMCC execution methodology can be seen in Chart 2.

Chart 2
Description of the execution of the Therapy Program for Management of Chronic Cough

DISCUSSION

TMCC was developed based on scientific knowledge and clinical experience, from the clinical characteristics and general needs of patients with refractory chronic cough, treatable with Speech-Language Pathology rehabilitation. A structured program to provide global cough rehabilitation that can be clinically reproduced in the Speech-Language Pathology treatment of this population.

Impartial and reliable scientific evidence on the effectiveness of TMCC, compared to traditional behavioral vocal therapy, in cases of refractory chronic cough, needs to be obtained by conducting a randomized clinical trial, already underway. Such data may assist the clinician in deciding on the best procedure for the rehabilitation of patients with refractory chronic cough.

CONCLUSION

TMCC synthesizes scientific knowledge and current clinical experience on the behavioral management of refractory chronic cough in a program with three main components, with specific objectives and strategies. The TMCC consists of four sessions, executed in hierarchical phases, with specific objectives and strategies per session.

  • Study conducted at Universidade Federal de São Paulo – UNIFESP - São Paulo (SP), Brasil.
  • Financial support: FAPESP (2018/06134-2).

REFERÊNCIAS

  • 1
    Vertigan AE, Theodoros DG, Gibson PG, Winkworth AL. The relationship between chronic cough and paradoxical vocal fold movement: a review of the literature. J Voice. 2006;20(3):466-80. http://dx.doi.org/10.1016/j.jvoice.2005.08.001 PMid:16274959.
    » http://dx.doi.org/10.1016/j.jvoice.2005.08.001
  • 2
    Morice AH, McGarvey L, Pavord I. Recommendations for the management of cough in adults. Thorax. 2006;61(Supl 1):1-24. http://dx.doi.org/10.1136/thx.2006.065144 PMid:16936230.
    » http://dx.doi.org/10.1136/thx.2006.065144
  • 3
    Poulose V, Bin Mohd I. Prolonged cough presenting with diagnostic difficulty: a study of aetiological and clinical outcomes. Singapore Med J. 2011;52(4):267-70. PMid:21552788.
  • 4
    Gibson PG, Vertigan AE. Speech pathology for chronic cough: a new approach. Pulm Pharmacol Ther. 2009;22(2):159-62. http://dx.doi.org/10.1016/j.pupt.2008.11.005 PMid:19061964.
    » http://dx.doi.org/10.1016/j.pupt.2008.11.005
  • 5
    Vertigan AE, Kapela SL, Ryan NM, Birring SS, McElduff P, Gibson PG. Pregabalin and speech pathology combination therapy for refractory chronic cough a randomized controlled trial. Chest. 2016;149(3):639-48. http://dx.doi.org/10.1378/chest.15-1271 PMid:26447687.
    » http://dx.doi.org/10.1378/chest.15-1271
  • 6
    Vertigan A, Gibson P. Speech pathology management of cronic refractory cough and related disorders. Oxford, UK: Coptom Publishing; 2016.
  • 7
    Vertigan AE, Kapela SM, Franke I, Gibson PG. The effect of a vocal loading test on cough and phonation in patients with chronic cough. J Voice. 2017;31(6):763-72. http://dx.doi.org/10.1016/j.jvoice.2017.03.020 PMid:28461166.
    » http://dx.doi.org/10.1016/j.jvoice.2017.03.020
  • 8
    Ryan NM, Gibson PG. Recent additions in the treatment of cough. J Thorac Dis. 2014;6(Supl 7):S739-47. http://dx.doi.org/10.3978/j.issn.2072-1439.2014.03.13 PMid:25383209.
    » http://dx.doi.org/10.3978/j.issn.2072-1439.2014.03.13
  • 9
    Chamberlain S, Birring SS, Garrod R. Nonpharmacological interventions for refractory chronic cough patients: systematic review. Lung. 2014;192(1):75-85. http://dx.doi.org/10.1007/s00408-013-9508-y PMid:24121952.
    » http://dx.doi.org/10.1007/s00408-013-9508-y
  • 10
    Gibson P, Wang G, McGarvey L, Vertigan AE, Altman KW, Birring SS, et al. Treatment of unexplained chronic cough chest guideline and expert panel report. Chest. 2016;149(1):27-44. http://dx.doi.org/10.1378/chest.15-1496 PMid:26426314.
    » http://dx.doi.org/10.1378/chest.15-1496
  • 11
    Ryan NM, Vertigan AE, Bone S, Gibson PG. Cough reflex sensitivity improves with speech language pathology management of refractory chronic cough. Cough. 2010;6(1):5. http://dx.doi.org/10.1186/1745-9974-6-5 PMid:20663225.
    » http://dx.doi.org/10.1186/1745-9974-6-5
  • 12
    Chamberlain S, Garrod R, Birring SS. Cough suppression therapy: does it work? Pulm Pharmacol Ther. 2013;26(5):524-7. http://dx.doi.org/10.1016/j.pupt.2013.03.012 PMid:23524013.
    » http://dx.doi.org/10.1016/j.pupt.2013.03.012
  • 13
    Vertigan AE, Theodoros DG, Gibson PG, Winkworth AL. Efficacy of speech pathology management for chronic cough: A randomised placebo controlled trial of treatment efficacy. Thorax. 2006;61(12):1065-9. http://dx.doi.org/10.1136/thx.2006.064337 PMid:16844725.
    » http://dx.doi.org/10.1136/thx.2006.064337
  • 14
    Vertigan AE, Theodoros DG, Winkworth AL, Gibson PG. A Comparison of two approaches to the treatment of chronic cough: perceptual, acoustic, and electroglottographic outcomes. J Voice. 2008;22(5):581-9. http://dx.doi.org/10.1016/j.jvoice.2007.01.001 PMid:17485195.
    » http://dx.doi.org/10.1016/j.jvoice.2007.01.001
  • 15
    Carroll TL. Chronic cough. San Diego, CA: LOGO Plural Publishing; 2019.

Publication Dates

  • Publication in this collection
    31 May 2021
  • Date of issue
    2021

History

  • Received
    01 Apr 2020
  • Accepted
    22 May 2020
Sociedade Brasileira de Fonoaudiologia Al. Jaú, 684, 7º andar, 01420-002 São Paulo - SP Brasil, Tel./Fax 55 11 - 3873-4211 - São Paulo - SP - Brazil
E-mail: revista@codas.org.br